Obgyn: Cervical Cancer: Free MSRA Podcast

🎧 FREE MSRA PODCAST – Cervical Cancer: Screening, Diagnosis & High-Yield MSRA RevisionReady to tackle one of the most essential gynaecology topics for the MSRA? This episode walks you through cervical cancer: what it is, who it affects, why screening matters, and how to remember the key facts. Ideal for rapid, memorable revision!📝 Key Learning Points📌 Definition & Epidemiology• Cervical cancer = malignancy of the cervix (lower uterus)• UK: 14th most common female cancer (c. 3,200 cases/year)• Globally: 4th most common – huge impact where screening is limited• 75% of UK cases diagnosed at early stage (I or II)• >50% cases under age 45; peak: 30–34 years📌 Causes & Risk Factors• Persistent high-risk HPV infection – especially types 16 & 18 (cause ~70% cases)• Other risks: – Smoking – Immunosuppression (HIV, transplant) – Early sexual activity, multiple partners – Long-term oral contraceptive use – Not attending screening💡 Mnemonic for revision: “S-I-S-S-O-N” – Smoking, Immunosuppression, Sexual history, Screening (missed), OCP, Non-attendance📌 Pathophysiology• Begins as precancerous changes (CIN 1/2/3)• Invasive cancer = abnormal cells break through basement membrane• Main types: squamous cell (~70–80%), adenocarcinoma (~15–20%)📌 Clinical Features• Often asymptomatic (caught via screening)• Symptoms: – Abnormal vaginal bleeding (postcoital, intermenstrual, postmenopausal) – Vaginal discharge, pelvic pain – Advanced: weight loss, leg swelling, urinary/bowel symptoms📌 Screening & Diagnosis• UK NHS Cervical Screening: – Ages 25–49: every 3 years; 50–64: every 5 years – Primary HPV testing first → cytology if positive – Abnormal results: referral to colposcopy + biopsy• Imaging (CT/MRI) for staging• HPV vaccination (types 16, 18, 6, 11) is highly effective prevention📌 Management• Depends on stage: – Early (IA1): cone biopsy or simple hysterectomy – Locally advanced: radical hysterectomy ± lymph nodes, chemoradiation – Advanced: palliative chemo/radiotherapy• Fertility-sparing (radical trachelectomy) possible in select early cases• No routine smear follow-up after cancer treatment; return to screening after 5 years if no recurrence📌 Prognosis & Complications• Prognosis best if caught early: – Stage IA1: 100% 5-year survival – IB2/IIB: 50–70% – III: 30–50% – IV: 5–15%• Complications: recurrence, local invasion, metastases, treatment effects (infertility, bladder/bowel issues)📎 More Cervical Cancer Revision Resources:📝 Revision Notes: https://www.passthemsra.com/topic/cervical-cancer-revision-notes/🧠 Flashcards: https://www.passthemsra.com/topic/cervical-cancer-flashcards/💬 Accordion Q&A: https://www.passthemsra.com/topic/cervical-cancer-accordion-qa-notes/🚀 Rapid Quiz: https://www.passthemsra.com/topic/cervical-cancer-rapid-quiz/🧪 Quiz Bank: https://www.passthemsra.com/quizzes/cervical-cancer/🎓 Full Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/#MSRA #CervicalCancer #MSRARevision #HPV #CervicalScreening #PassTheMSRA #ObstetricsAndGynaecology